Abstract
No public abstract is available from the verified source records.
Alessandro Viti, Vito Cucchiara
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/s0140-6736(26)01092-5
10.1016/s0140-6736(26)01092-5
Unresolved referenced work
Kept as external metadata until matched
Radiographic progression-free survival and clinical progression-free survival as potential surrogates for overall survival in men with metastatic hormone-sensitive prostate cancer
10.1200/jco.23.01535 · 2024
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
10.1016/s1470-2045(24)00440-6 · 2024
177Lu-PSMA-617 consolidation therapy after docetaxel in patients with synchronous high-volume metastatic hormone-sensitive prostate cancer: a randomized, phase 2 trial
2025
177Lu-prostate-specific membrane antigen neoadjuvant to stereotactic ablative radiotherapy for oligorecurrent prostate cancer (LUNAR): an open-label, randomized, controlled, phase II study
10.1200/jco-25-01553 · 2025
Trial design and objectives for patients with prostate cancer: recommendations from the Prostate Cancer Working Group 4
10.1200/jco-25-02834 · 2026
Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade
10.2967/jnumed.118.223099 · 2019
Unresolved referenced work
Kept as external metadata until matched
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
10.1038/s43018-023-00539-6 · 2023
Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intratumoral PSMA heterogeneity
10.1158/1078-0432.ccr-19-1485 · 2020
No additional external references are available.